Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
13.09 Down 0.61(4.45%) 4:00PM EDT
|After Hours : 13.10 Up 0.01 (0.08%) 6:25PM EDT
Prev Close:13.70
Open:13.50
Bid:13.13 x 500
Ask:N/A
1y Target Est:36.29
Beta:3.17
Next Earnings Date: 6-Aug-14CLDX Earnings announcement
Day's Range:13.00 - 13.68
52wk Range:10.76 - 38.84
Volume:1,661,773
Avg Vol (3m):2,455,880
Market Cap:1.17B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXDown 4.45%1.17B
DNDNDown 1.43%321.08M
LLYDown 2.49%65.44B
RHHBYDown 1.36%246.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):579.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Jun-14) :-0.32
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback